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InTRoDucTIon
A great number of skin manifestations have been 
related to the underlying internal malignancy (1). 
Skin changes can often be the first sign of a serious 
problem. A relationship of some dermatoses with 
malignancy has been frequently determined and the 
associated dermatoses are accepted as paraneoplas-
tic. The clinical manifestations of these dermatoses 
may precede, coincide with or follow the diagno-
sis of internal malignancy. In the current literature, 
many cases are presented with sudden appearance 
of multiple pruritic seborrheic keratoses related to 
the underlying internal malignancy (2-7). Although 
some authors have accepted that the sign of Leser-
Trélat is a cutaneous marker of internal malignancies, 
it is still a matter of debate whether the syndrome is 
a paraneoplastic disorder or not (8-13). A patient with 
the sign of Leser-Trélat presented to our clinic, but no 
internal malignancy could be determined despite de-
tailed examination.
caSE REpoRT
A 37-year-old female patient was admitted to our 
clinic because of serpigo on her neck that had ap-
peared less than a month before and increased in 
number rapidly. Her past medical history and family 
history were unremarkable. On dermatological exam-
ination, 2-10 mm sized brown and slightly verrucous 
papules were observed on the neck and upper chest 
(Fig. 1). Histopathology of the lesion showed acan-
thosis, hyperkeratosis and papillomatosis (Fig. 2).
The patient was examined for internal malignan-
cy. Laboratory analyses for liver and kidney function, 
electrolytes, protein electrophoresis, blood and urine 
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SummaRy Leser-Trélat sign is a rare cutaneous disorder that 
manifests with sudden emergence of seborrheic keratoses and 
increase in their numbers and size within weeks or months. Its 
concurrence with many types of malignancies, especially adeno-
carcinoma and lymphoma, has been reported in the literature. In 
this case report, a patient having Leser-Trélat sign, without any 
detected malignancy in spite of detailed examination and 18 
months of follow up, is presented. Current literature is reviewed 
in relation to the debate whether Leser-Trélat is a paraneoplastic 
syndrome or not. 
KEy woRDS: Leser-Trélat sign, seborrheic keratoses, paraneo-
plastic syndrome
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tests were all within the normal range. Chest x-ray 
and abdominal ultrasonography revealed no patho-
logic signs. Erythrocyte sedimentation rate was 30 
mm/hour and tests for viral hepatitis, HIV and syphilis 
were negative. No abnormality was detected on ab-
dominal, cranial and thorax tomography. Otolaryn-
gological examination was normal. Esophagogastro-
duodenoscopy and colonoscopy were also normal. 
The patient was healthy and no change was observed 
on seborrheic keratoses during one-year follow up.
DIScuSSIon
Paraneoplastic syndromes are a group of clini-
cal manifestations that are associated with a malig-
nancy and can progress without being related to a 
primary tumor or metastases. Characteristically, their 
progresses show parallelism with tumor progresses. 
Although their mechanism is not fully known, bioac-
tive substances (such as polypeptide hormones, hor-
mone-like peptides, antibodies or immune complex-
es, cytokines, or growth factors), which are released 
by the tumor or as a response to tumor, are consid-
ered responsible (1).
The sign of Leser-Trélat is characterized by the pro-
gression of new seborrheic keratoses in an eruptive 
way, or increase in their size within weeks or months. 
According to some researchers, this cutaneous dis-
order is a paraneoplastic syndrome (2). The most 
frequently reported malignancies associated with 
Leser-Trélat sign are stomach cancer, gastrointestinal 
adenocarcinoma and lymphoma. In the literature, 
leukemia, lymphoma, mycosis fungoides, Sezary syn-
drome, and breast, lung and prostate carcinomas and 
sarcomas (neurofibrosarcoma) associated with Leser-
Trélat sign have also been reported (14).
The sign of Leser-Trélat has been reported even in 
situations where no malignancy was detected, such 
as in heart transplant recipients, erythrodermic pity-
riasis rubra pilaris, and HIV infection (15-17). Leser-
Trélat sign was defined separately by Edmund Leser 
and Ulysse Trélat and was first described together 
with eruptive cherry angiomas in patients having in-
ternal malignancy (14). However, Holländer was the 
first to show the relationship of seborrheic keratoses 
and cancer (18,19), but the name of Leser-Trélat was 
given to this sign.
The criteria for Leser-Trélat sign defined by Ron-
chese are rapid increase in seborrheic keratoses on 
lesion-free skin, pruritus and an accompanying inter-
nal malignancy (20). Heaphy et al. have suggested to 
use the term of Leser-Trélat syndrome to describe the 
cases with accompanying internal malignancy (21). 
The pathomechanism of the sign of Leser-Trélat 
is unknown. The cause of the increase in size and 
number of seborrheic keratoses is thought to be an 
induction of epidermal proliferation associated with 
a growth factor that originates from the tumor and is 
swept into the circulation (22). 
Schwengle et al. studied 36 cancer patients, many 
of whom had adenosarcomas, and they found that 
the sizes and numbers of seborrheic keratoses in the 
cancer patient group were not different from those 
in the control group (12). Grob et al. determined the 
sign of Leser-Trélat in only one patient out of 82 pa-
tients with solid organ cancers and again in only one 
Figure 2. Marked acanthosis of predominantly ba-
saloid cells, papillomatosis, hyperkeratosis and horn 
cysts (HE; x40)
Figure 1. Multiple seborrheic keratoses on the neck 
scattering to the upper chest. 
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patient in the control group consisting of 82 patients 
(11). Similar findings were obtained in another study 
of 150 oncology patients compared with 150 healthy 
people (13). These researchers suggested that this 
sign was coincidental (11-13). 
For the Leser-Trélat sign, even if the term “paraneo-
plastic” is used widely, we think that it is controversial 
because the incidence of both seborrheic keratoses 
and cancer is increased in old-aged population and 
the probability of this concurrence being coinciden-
tal is pretty high, as stated by Schwengle et al. (12) 
and Fink et al. (13). 
Remission of paraneoplastic dermatosis should 
be expected after the tumor has been cured if ma-
lignancy and paraneoplastic dermatosis show paral-
lel progression (23). A real paraneoplastic dermatosis 
reappears when cancer recurs or metastasizes. In the 
literature, this fact is not introduced clearly, and after 
treatment of primary cancer, recession is observed 
only in one-third of seborrheic keratoses (21). 
A sudden increase of seborrheic keratoses is com-
pletely based on subjective evaluation of the patient, 
and it is hardly reliable. This sudden increase can be 
related with the consciousness/awareness level of 
the patient who had cancer diagnosis, as mentioned 
by Schwengle et al. (12). Additionally, Brauer states 
that there is no plausible definition of distinction 
between eruptive seborrheic keratosis and common 
seborrheic keratosis (24).
concLuSIon
By reviewing literature data, the results of stud-
ies on the relation between Leser-Trélat sign and 
malignancy are inconsistent and there is no strong 
evidence for the presence of the sign. Almost all pub-
lications that claim coincidence of this sign with ma-
lignancy consist of case reports. Studies investigating 
the etiopathogenesis could not show any substance 
released by or in response to tumor. In our opinion, 
eruptive seborrheic keratoses do not require search-
ing for an underlying internal malignancy. However, 
to be able to understand whether the Leser-Trélat 
sign really exists, the presence of malignancy should 
be searched in a broad case series consisting of pa-
tients with eruptive seborrheic keratoses. 
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